• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肥厚型心肌病患者的心脏黏液瘤

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy.

作者信息

Gi Weng-Tein, Sedaghat-Hamedani Farbod, Shirvani Samani Omid, Kayvanpour Elham, Herpel Esther, Arif Rawa, Riffel Johannes, Mereles Derliz, Katus Hugo A, Meder Benjamin

机构信息

Department of Medicine III, Institute for Cardiomyopathy, University of Heidelberg, Heidelberg, Germany.

German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.

出版信息

JACC Case Rep. 2020 Feb 12;2(3):378-383. doi: 10.1016/j.jaccas.2019.11.072. eCollection 2020 Mar.

DOI:10.1016/j.jaccas.2019.11.072
PMID:34317246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8311620/
Abstract

We report a rare case of concomitant hypertrophic cardiomyopathy and cardiac myxoma without LEOPARD syndrome. Additionally, 6 similar cases were systemically reviewed, and the characteristics of this first-ever studied patient group were summarized. ().

摘要

我们报告了一例罕见的同时患有肥厚型心肌病和心脏黏液瘤且无豹皮综合征的病例。此外，还对6例类似病例进行了系统回顾，并总结了这个首次研究的患者群体的特征。（）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/7663ce2aabbc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/3fd8cf771cc7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/688e0d5337e0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/06ae3df4754e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/944a29bec1e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/36f70acf3731/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/7663ce2aabbc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/3fd8cf771cc7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/688e0d5337e0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/06ae3df4754e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/944a29bec1e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/36f70acf3731/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02b/8311620/7663ce2aabbc/gr5.jpg

相似文献

1
Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy.肥厚型心肌病患者的心脏黏液瘤
JACC Case Rep. 2020 Feb 12;2(3):378-383. doi: 10.1016/j.jaccas.2019.11.072. eCollection 2020 Mar.
2
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.肥厚型心肌病 NHLBI 登记处的不同亚组。
J Am Coll Cardiol. 2019 Nov 12;74(19):2333-2345. doi: 10.1016/j.jacc.2019.08.1057.
3
The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.可溶性ST2和半乳糖凝集素-3作为肥厚型心肌病中用于更好风险分层的新型生物标志物的效用。
Kardiol Pol. 2017;75(10):997-1004. doi: 10.5603/KP.a2017.0118. Epub 2017 Jun 14.
4
[Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].[2014年欧洲指南心脏性猝死风险预测模型（HCM Risk-SCD）对中国肥厚型心肌病患者的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1033-1038. doi: 10.3760/cma.j.issn.0253-3758.2017.12.006.
5
Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy.NT-proBNP和hs-cTnT与肥厚型心肌病舒张功能障碍及局灶性心肌纤维化影像学标志物的关联
Life (Basel). 2022 Aug 16;12(8):1241. doi: 10.3390/life12081241.
6
Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.根据 2014 年 ESC 指南，肌钙蛋白水平升高而非 N 末端脑利钠肽前体与肥厚型心肌病患者发生心源性猝死风险增加相关。
Dis Markers. 2017;2017:9417908. doi: 10.1155/2017/9417908. Epub 2017 Nov 20.
7
Asymptomatic Apical Hypertrophic Cardiomyopathy in an Elite Competitive Athlete.一名优秀竞技运动员的无症状性心尖肥厚型心肌病
JACC Case Rep. 2022 Dec 13;6:101705. doi: 10.1016/j.jaccas.2022.101705. eCollection 2023 Jan 18.
8
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者心源性猝死风险分层中的价值及延迟钆增强分布情况
J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9.
9
Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.N端前B型利钠肽和心肌肌钙蛋白I对肥厚性梗阻性心肌病心肌纤维化的预测价值
PLoS One. 2016 Jan 14;11(1):e0146572. doi: 10.1371/journal.pone.0146572. eCollection 2016.
10
Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.血浆N末端脑钠肽前体：肥厚型心肌病左心室肥厚的一个标志物。
Rev Port Cardiol. 2004 Dec;23(12):1557-82.

引用本文的文献

1
Case report: Left atrial myxoma with morphology of cavernous hemangioma supplied by the right coronary artery.病例报告：具有海绵状血管瘤形态且由右冠状动脉供血的左心房黏液瘤。
Front Cardiovasc Med. 2023 Aug 1;10:1207339. doi: 10.3389/fcvm.2023.1207339. eCollection 2023.
2
A Case Report on the Incidental Diagnosis of a Left Atrial Myxoma in a Patient Presenting With Right Shoulder Pain and Inter-scapular Back Pain.一例以右肩痛和肩胛间背痛为表现的患者偶然诊断为左心房黏液瘤的病例报告。
Cureus. 2022 Mar 15;14(3):e23187. doi: 10.7759/cureus.23187. eCollection 2022 Mar.
3
The Ever-Expanding Landscape of Cardiomyopathies.

本文引用的文献

1
Cardiac MR assessment of cardiac myxomas.心脏黏液瘤的心脏磁共振评估。
Br J Radiol. 2015 Jan;88(1045):20140599. doi: 10.1259/bjr.20140599.
2
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会（ESC）肥厚型心肌病诊断和治疗指南：欧洲心脏病学会（ESC）肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
3
Hypertrophic cardiomyopathy and left atrial myxoma.
心肌病不断扩展的领域
JACC Case Rep. 2020 Mar 18;2(3):361-364. doi: 10.1016/j.jaccas.2020.02.006. eCollection 2020 Mar.
肥厚型心肌病和左心房黏液瘤。
Pol Arch Med Wewn. 2014;124(6):336-7. Epub 2014 Apr 29.
4
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).肥厚型心肌病患者心脏性猝死的新型临床风险预测模型（HCM risk-SCD）。
Eur Heart J. 2014 Aug 7;35(30):2010-20. doi: 10.1093/eurheartj/eht439. Epub 2013 Oct 14.
5
Atrial myxoma in a patient with hypertrophic cardiomyopathy.肥厚型心肌病患者的心房黏液瘤。
Tex Heart Inst J. 2013;40(4):462-4.
6
LEOPARD Syndrome: Clinical Features and Gene Mutations.豹皮综合征：临床特征与基因突变
Mol Syndromol. 2012 Oct;3(4):145-57. doi: 10.1159/000342251. Epub 2012 Aug 29.
7
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.信号转导与心肌肥厚：来自人类和小鼠 RAS opathy 的新视角。
Mol Med. 2012 Sep 7;18(1):938-47. doi: 10.2119/molmed.2011.00512.
8
Diagnosis and treatment of cardiac myxomas by transesophageal echocardiography.经食管超声心动图对心脏黏液瘤的诊断与治疗
Am J Cardiol. 2002 Dec 15;90(12):1419-21. doi: 10.1016/s0002-9149(02)02891-6.
9
Combined apical hypertrophic cardiomyopathy and left atrial myxoma.合并心尖肥厚型心肌病和左心房黏液瘤。
Chest. 1992 Apr;101(4):1149-50. doi: 10.1378/chest.101.4.1149.